Cargando…
Complement, thrombotic microangiopathy and disseminated intravascular coagulation
In the blurring boundaries between clinical practice and scientific observations, it is increasingly attractive to propose shared disease mechanisms that could explain clinical experience. With the advent of available therapeutic options for complement inhibition, there is a push for more widespread...
Autores principales: | Kurosawa, Shinichiro, Stearns-Kurosawa, Deborah J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336180/ https://www.ncbi.nlm.nih.gov/pubmed/25705421 http://dx.doi.org/10.1186/s40560-014-0061-4 |
Ejemplares similares
-
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
por: Wada, Hideo, et al.
Publicado: (2018) -
Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation
por: Sakamaki, Yusuke, et al.
Publicado: (2013) -
Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know
por: Vincent, Jean-Louis, et al.
Publicado: (2018) -
Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report
por: Abe, Tomohiro, et al.
Publicado: (2017) -
An Immunocompetent Case of Capnocytophaga canimorsus Infection Complicated by Secondary Thrombotic Microangiopathy and Disseminated Intravascular Coagulation
por: Tani, Naoki, et al.
Publicado: (2019)